Literature DB >> 25539863

Comparison of TGFbR2 down-regulation in expanded HSCs on MBA/DBM scaffolds coated by UCB stromal cells.

Zahra Sadat Hashemi1, Mehdi Forouzandeh Moghadam, Masoud Soleimani.   

Abstract

Bone marrow transplants (BMTs) are mainly limited by a low number of CD34(+) cells. The transforming growth factor-beta (TGF-β) pathway downregulation is a key factor that increases cell self-renewal. In nature, hematopoietic stem cells (HSCs) are in a microenvironment, surrounded by cells in a three-dimensional (3D) configuration. The aim of this study is to investigate the association between a 3D culture and the delivery ratio of downregulation. Demineralized bone matrix (DBM) and mineralized bone allograft (MBA) scaffolds were coated using unrestricted somatic stem cells (USSCs) as the feeder layer. Umbilical cord blood (UCB)-CD34(+) cells were then ex vivo expanded in them and transfected by small interfering RNA (siRNA) against TGFbR2, a type 2 receptor in the TGF-β pathway. Finally, quantitative real-time PCR, flow cytometry, and clonogenic assay were performed. In a global comparison, we observed that the highest expansion ratio, lowest expression level, and the highest CD34 marker belonged to the simple 2D culture transfected group. This suggests that TGFbR2 downregulation in a 2D culture can be done more effectively. The siRNA delivery system and the transfection ratio in an ex vivo environment, which mimicks in vivo conditions, have low efficiency. Genetic modification of the cells needs free 3D spaces to enable better transfection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25539863     DOI: 10.1007/s11626-014-9854-y

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  50 in total

1.  Application of scaffold materials in tissue reconstruction in immunocompetent mammals: our experience and future requirements.

Authors:  Wei Liu; Yilin Cao
Journal:  Biomaterials       Date:  2007-07-31       Impact factor: 12.479

2.  Hematopoietic stem cell transplantation in acute promyelocytic leukemia, experience in Iran.

Authors:  Kamran Alimoghaddam; Ardeshir Ghavamzadeh; Mohammad Jahani; Arash Jalali; Hoda Jorjani; Massoud Iravani; Amir Ali Hamidieh; Asadolah Mousavi; Babak Bahar; Maryam Behfar; Roshanak Derakhshandeh; Shahrbanoo Rostami
Journal:  Arch Iran Med       Date:  2011-09       Impact factor: 1.354

3.  Human umbilical cord blood-derived stromal cell, a new resource of feeder layer to expand human umbilical cord blood CD34+ cells in vitro.

Authors:  Lei Gao; Xinghua Chen; Xi Zhang; Yao Liu; Peiyan Kong; Xiangui Peng; Lin Liu; Hong Liu; Dongfeng Zeng
Journal:  Blood Cells Mol Dis       Date:  2006-02-24       Impact factor: 3.039

Review 4.  Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: the next generation of cellular therapeutics.

Authors:  S G Emerson
Journal:  Blood       Date:  1996-04-15       Impact factor: 22.113

5.  Comparison of human bone marrow stromal cells seeded on calcium-deficient hydroxyapatite, beta-tricalcium phosphate and demineralized bone matrix.

Authors:  P Kasten; R Luginbühl; M van Griensven; T Barkhausen; C Krettek; M Bohner; U Bosch
Journal:  Biomaterials       Date:  2003-07       Impact factor: 12.479

6.  Autocrine transforming growth factor beta 1 blocks colony formation and progenitor cell generation by hemopoietic stem cells stimulated with steel factor.

Authors:  R E Ploemacher; P L van Soest; A Boudewijn
Journal:  Stem Cells       Date:  1993-07       Impact factor: 6.277

7.  Secondary repair of alveolar clefts using human mesenchymal stem cells.

Authors:  Hossein Behnia; Arash Khojasteh; Masoud Soleimani; Azita Tehranchi; Ahad Khoshzaban; Saeed Hidari Keshel; Reza Atashi
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-08

8.  Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand.

Authors:  Y Ohmizono; H Sakabe; T Kimura; S Tanimukai; T Matsumura; H Miyazaki; S D Lyman; Y Sonoda
Journal:  Leukemia       Date:  1997-04       Impact factor: 11.528

9.  In vitro growth of human fetal CD34+ cells in the presence of various combinations of recombinant cytokines under serum-free culture conditions.

Authors:  G Zauli; M Vitale; G Visani; M Marchisio; D Milani; S Capitani
Journal:  Br J Haematol       Date:  1994-03       Impact factor: 6.998

10.  Crosslinked three-dimensional demineralized bone matrix for the adipose-derived stromal cell proliferation and differentiation.

Authors:  Yannan Zhao; Hang Lin; Jing Zhang; Bing Chen; Wenjie Sun; Xia Wang; Wenxue Zhao; Zhifeng Xiao; Jianwu Dai
Journal:  Tissue Eng Part A       Date:  2009-01       Impact factor: 3.845

View more
  5 in total

1.  Enhanced Osteoinductivity of Demineralized Bone Matrix with Noggin Suppression in Polymer Matrix.

Authors:  Chen Chen; Matthew Rehnama; Soyon Kim; Chung-Sung Lee; Xiao Zhang; Tara Aghaloo; Jiabing Fan; Min Lee
Journal:  Adv Biol (Weinh)       Date:  2021-01-04

2.  Inhibition of breast cancer metastasis by co-transfection of miR-31/193b-mimics.

Authors:  Zahra Sadat Hashemi; Mehdi Forouzandeh Moghadam; Samila Farokhimanesh; Masoumeh Rajabibazl; Esmaeil Sadroddiny
Journal:  Iran J Basic Med Sci       Date:  2018-04       Impact factor: 2.699

3.  Bushenhuoxue Formula Facilitates Articular Cartilage Repair and Attenuates Matrix Degradation by Activation of TGF-β Signaling Pathway.

Authors:  Rui Dong; Jun Ying; Taotao Xu; Songfeng Hu; Peng Zhang; Chenjie Xia; Liang Fang; Hongting Jin; Pinger Wang
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-08       Impact factor: 2.629

4.  Bioactivity of Exosomes Derived from Trained Natural Killer Cells versus Non-Trained One: More Functional and Antitumor Activity.

Authors:  Fateme Mohammadi; Zahra Sadat Hashemi; Ramin Sarrami Forooshani; Shaban Alizadeh
Journal:  Biomed Res Int       Date:  2022-08-24       Impact factor: 3.246

5.  miR-29b Regulates Lung Cancer Progression by Downregulating FEM1B and Inhibiting the FOX01/AKT Pathway.

Authors:  Huanrong Zhang; Rong Wang; Qiuhua Deng
Journal:  Comput Math Methods Med       Date:  2022-08-14       Impact factor: 2.809

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.